GUARDANT HEALTH INC (GH) Stock News
NASDAQ:GH - Nasdaq - US40131M1099 - Common Stock - Currency: USD
GH Latest News, Press Relases and Analysis
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.
Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
TEM's Genomics revenues soar 89% on oncology test gains and Ambry Genetics' boost. New assays could fuel more growth.
Guardant Health: A Promising Player in the Liquid Biopsy Market
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
Smart Beta ETF report for FNY
Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
Cathie Wood sells $22.8 million of hot stock near all-time highs
Here are Cathie Wood’s latest moves.
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
TEM's rapid growth and cost discipline are paving the way for a positive adjusted EBITDA in 2025.
Elastic N.V. (ESTC) Sees Price Target Cut on Weak Federal Growth, But Generative AI Still a Bright Spot
We recently published a list of 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Elastic NV. (NYSE:ESTC) stands against other AI stocks on Wall Street’s radar. On June 2nd, Citi analyst Tyler Radke lowered the price target on Elastic NV. (NYSE: ESTC) to $125.00 […]
Peloton launches peer-to-peer resale platform
The exercise company launched a beta version of Peloton Repowered in select metro areas, offering special discounts to buyers and sellers.
Why Guardant Health Stock Surged Nearly 9% Higher Today
The company's Shield multi-cancer detection test won an important designation from a top regulator. Precision oncology specialist Guardant Health (NASDAQ: GH) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost 9% higher today.
Why Guardant Health Stock Surged Nearly 9% Higher Today
Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?
Guardant Health's Shield test receives FDA breakthrough status and NCCN guideline inclusion, with high accuracy shown in new ASCO and ECLIPSE study data.
FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test
National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test
Fidelity (FIS) Partners with Letskipp to Market Non-Sufficient Funds Authorization Solution
On May 21, Fidelity National Information Services, Inc. (NYSE:FIS) announced a strategic partnership with Letskipp Ltd. to introduce an innovative non-sufficient funds (NSF) authorization solution for its debit clients. Fidelity National Information Services, Inc. (NYSE:FIS) is a leading international financial technology company providing a range of services for financial institutions, businesses, and developers. Letskipp Ltd. […]
MSCI Inc (MSCI) Signs a MOU with Intapp (INTA) to Innovate Capital Markets Using AI
On May 21, MSCI Inc. (NYSE:MSCI) announced signing a memorandum of understanding with Intapp, Inc. (NASDAQ:INTA) to provide enhanced capital market intelligence using artificial intelligence. MSCI Inc. (NYSE:MSCI) provides critical decision-making tools for the investment community, including institutional investors, asset managers, wealth managers, and financial intermediaries. On the other hand, Intapp, Inc. (NASDAQ:INTA) is an […]
Unifi (UFI) Closes the Sale of its Manufacturing Facility in Madison
On May 21, Unifi, Inc. (NYSE:UFI) announced the closing of the sale of its manufacturing facility in Madison, North Carolina, to a third-party buyer. Management notes that the proceeds of the sales are to be allocated to reduce debt, enhance future performance, and strengthen the balance sheet. Unifi, Inc. (NYSE:UFI) is a leading fiber science […]
TD Cowen Maintains a Buy Rating on Warby (WRBY) After Google Partnership
On May 21, TD Cowen analyst Oliver Chen raised the price target on Warby Parker Inc. (NYSE:WRBY) from $20 to $24 while maintaining a Buy rating on the stock. The analyst raised the price target after the company announced its partnership with Alphabet Inc. (NASDAQ:GOOGL) to develop AI glasses compatible with Android and iOS. Warby […]
Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
Guardant Health to Participate in Upcoming Investor Conferences
TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year
